07 Jan 2001

Tepazepan 30 - España

Updated: 07 Jan 2001

Tepazepan 30 capsulas

Neurosis orgánicas y funcionales. Alteraciones psicosomáticas. Psicosis moderadas acompañadas de ansiedad o angustia.

Tepazepan 30 Description, Presentation and Dosage

Tepazepan 30 Description

Tepazepan 30 Drug Class Description

Asociaciones de antipsicoticos con ansioliticos

Tepazepan 30 Drug Description

CAPSULAS

Tepazepan 30 Presentation

Tepazepan 30 Presentation

Oral. Adultos: 1-3 cápsulas al día.

Tepazepan 30 Manufacturer

ALMIRALL PRODESFARMA

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

Oral Anticoagulation Reversal Knowledge Centre

Oral Anticoagulation Reversal Knowledge Centre

The Oral Anticoagualtion Reversal Knowledge Centre is intended to provide healthcare professionals with accurate information on the approaches to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding, or require surgery. Content is arranged within illustrated and referenced sections including management of bleeding risk, oral anticoagulants, symposium highlights, key publication summaries and more.

This resource is developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with content provided by CSL Behring.

This resource is not intended for healthcare professionals outside Europe.

Tepazepan 30 Dosage

Tepazepan 30 Precautions, Reactions and Contraindications

Tepazepan 30 Special Precautions

Tepazepan 30 Special Precautions

Precaución en pacientes con afecciones renales y/o hepáticas, hipertensión o feocromocitoma. Puede disminuir la capacidad de concentración y los reflejos: Cuidado al conducir, especialmente al comienzo del tratamiento. Evitar consumir bebidas alcohólicas bajo su efecto. Después de 3-4 meses evitar la suspensión brusca del tratamiento. En ancianos y pacientes debilitados controlar la dosificación.

Tepazepan 30 Adverse Reactions

Tepazepan 30 Adverse Reactions

Somnolencia, sedación, fatiga pasajera. Galactorrea, alteraciones menstruales (excepcionalmente).

Tepazepan 30 Contraindications

Tepazepan 30 Contraindications

Hipersensibilidad a alguno de los componentes. Miastenia grave.

Related Drugs - Medicina tropical

Back to top